Management of Postural Orthostatic Tachycardia Syndrome (POTS)

Initial Non-Pharmacological Management

All patients with POTS should immediately begin non-pharmacological interventions including 2-3 liters of fluid daily, 5-10g of dietary salt, waist-high compression garments, and a structured exercise program starting with recumbent positions, with pharmacological therapy added based on the specific POTS phenotype (hypovolemic, neuropathic, or hyperadrenergic) 1, 2
Increase fluid intake to 2-3 liters per day to maintain adequate blood volume and reduce orthostatic symptoms 1, 2
Consume 5-10g (1-2 teaspoons) of table salt daily through liberalized dietary sodium intake, avoiding salt tablets which cause gastrointestinal side effects 1, 2
Elevate the head of the bed by 10 degrees during sleep to prevent nocturnal polyuria, maintain favorable fluid distribution, and promote chronic volume expansion 1, 2
Use waist-high compression garments or abdominal binders extending at least to the xiphoid to reduce venous pooling in lower extremities 1, 2
Teach physical counter-pressure maneuvers including leg-crossing, squatting, stooping, muscle tensing, and squeezing a rubber ball during symptomatic episodes for immediate symptom relief 1, 2
Regular cardiovascular exercise addresses the cardiovascular deconditioning (cardiac atrophy and hypovolemia) that significantly contributes to POTS 2

For hypovolemic POTS, fludrocortisone 0.1-0.3 mg once daily stimulates renal sodium retention and expands fluid volume 1, 2
For neuropathic POTS, midodrine 2.5-10 mg three times daily enhances vascular tone through peripheral α1-adrenergic agonism 1, 2
For hyperadrenergic POTS, propranolol or other beta-blockers are specifically indicated for patients with resting tachycardia and hyperadrenergic features 1, 2

Monitor for supine hypertension when using vasoconstrictors like midodrine 1, 2
Carefully adjust or withdraw any medications that may cause hypotension including antihypertensives and medications that lower CSF pressure 1, 2
For heart rates reaching 180 bpm, perform cardiac evaluation to rule out other arrhythmias before attributing symptoms solely to POTS 1, 2

Assess standing heart rate and symptom improvement as primary outcome measures 1, 2
Monitor peak symptom severity, time able to spend upright before needing to lie down, and cumulative hours able to spend upright per day 1

When Mast Cell Activation Syndrome (MCAS) is suspected, treat with histamine receptor antagonists and/or mast cell stabilizers 3
Consider a gastroparesis diet (small particle diet) for upper GI symptoms 3
Consider coenzyme Q10 and d-ribose for patients with concurrent chronic fatigue syndrome 1, 2

Do not use beta-blockers indiscriminately—they are specifically indicated for hyperadrenergic POTS, not for reflex syncope or other POTS phenotypes 1
Recognize that syncope is rare in POTS and usually elicited by vasovagal reflex activation, not the POTS itself 2
POTS is frequently associated with deconditioning, recent infections, chronic fatigue syndrome, and joint hypermobility syndrome—screen for these conditions 1, 2